Skip to main content
SpringerLink
Log in

Risk Factors for Pelvic Inflammatory Disease and Associated Sequelae

  • Chapter
Pelvic Inflammatory Disease

  • 165 Accesses

Abstract

Unlike an infectious disease associated with the presence of a particular etiologic agent, pelvic inflammatory disease (PID) is a syndrome or constellation of symptoms that can result from multiple etiologic pathways. Approximately 75% of PID is associated with progression of an initial infection from various sexually transmitted disease (STD) pathogens in the lower genital tract into the upper genital tract.1 In cases of PID not associated with an initial STD, the initial exposure may involve a mechanical insult (e.g., traumatic birth, abortion, and IUD insertion) that may result in a perturbation of the normal flora of the vagina, or a disruption such that the normal flora of the lower genital tract flora ascends into the en-dometrial cavity or fallopian tubes.2 Of course it is possible that this pathogenic mechanism may also occur from disturbances caused by STD infections.2

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Rice PA, Schachter J. Pathogenesis of pelvic inflammatory diseases. JAMA 1991;266:2587–2594.

    Article  PubMed  CAS  Google Scholar 

  2. Wasserheit J. Pelvic inflammatory disease and infertility. Md Med J 1987;36: 58–63.

    PubMed  CAS  Google Scholar 

  3. Pearce M. Pelvic inflammatory disease. BMJ 1990;300:1090–1091.

    Article  PubMed  CAS  Google Scholar 

  4. Cates W, Rolfs R, Aral S. Sexually transmitted diseases, pelvic inflammatory disease, and infertility: An epidemiologic update. Epidemiol Rev 1990;12: 199–220.

    PubMed  Google Scholar 

  5. Washington AE, Aral S, Wølner-Hanssen P, et al. Assessing risk for pelvic inflammatory disease and its sequelae. JAMA 1991;266:2581–2586.

    Article  PubMed  CAS  Google Scholar 

  6. Padian N, Shiboski S, Hitchcock P. Risk factors for acquisition of sexually transmitted diseases and development of complications, in Wasserheit J, Aral S, Holmes K, Hitchcock P, (eds): Research Issues in Human Behavior and Sexually Transmitted Diseases in the AIDS Era. Washington, DC. Am. Soc. Microbiology 1991, pp 83–96.

    Google Scholar 

  7. May R, Anderson R. Transmission dynamics of HIV infection. Nature 1987;326:137–142.

    Article  PubMed  CAS  Google Scholar 

  8. Lilienfeld A, Lilienfeld D. Foundations of Epidemiology. New York, Oxford University Press, 1980.

    Google Scholar 

  9. Washington AE, Gove S, Schachter J, et al. Oral contraceptives, Chlamydia trachomatis infection and pelvic inflammatory disease: A word of caution about protection. JAMA 1985;253:2246–2250.

    Article  PubMed  CAS  Google Scholar 

  10. Wølner-Hanssen P, Eschenbach DA, Paavonen J, et al. Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use. JAMA 1990;263:54–59.

    Article  PubMed  Google Scholar 

  11. Senanayake P, Kramer D. Contraception and the etiology of pelvic inflammatory disease: New perspectives. Am J Obstet Gynecol 1980;138:852–860.

    PubMed  CAS  Google Scholar 

  12. McGowan L. Peritonitis following the vaginal douche and a proposed alternative method for vaginal and vulvar care. Am J Obstet Gynecol 1965;93:506–509.

    PubMed  CAS  Google Scholar 

  13. Egenolf G, McNaughton R. Chemical peritonitis resulting from vaginal douche: Report of a case. Obstet Gynecol 1956;7:23–24.

    PubMed  CAS  Google Scholar 

  14. Chow J, Yonekura L, Richwald G, et al. The association between Chlamydia trachomatis and ectompic pregnancy: A matched-pair, case-control study. JAMA 1990;263:3164–3167.

    Article  PubMed  CAS  Google Scholar 

  15. Wølner-Hanssen P, Eschenbach D, Paavonen J, et al. Association between vaginal douching and acute pelvic inflammatory disease. JAMA 1990;263:1936–1941.

    Article  PubMed  Google Scholar 

  16. Rosenberg MJ, Phillips RS, Holmes MD. Vaginal douching: Who and why? J Reprod Med 1991;36(10):753–758.

    Google Scholar 

  17. Lee NC, Rubin G, Ory H, et al. Type of intrauterine device and the risk of pelvic inflammatory disease. Obstet Gynecol 1983;62:l-6.

    Google Scholar 

  18. Grimes D. Intrauterine devices and pelvic inflammatory disease: Recent developments. Contraception 1987;36:97–109.

    Article  PubMed  CAS  Google Scholar 

  19. Farley T, Rosenberg M, Rowe P, et al. Intrauterine devices and pelvic inflammatory disease: An international perspective. Lancet 1992;l:785–788.

    Google Scholar 

  20. Sinei S, Schulz K, Lamptey P, et al. Preventing IUCD-related pelvic infection: The efficacy of prophylactic doxycycline at insertion. Br J Obstet Gynaecol 1990;97:412–419.

    Article  PubMed  CAS  Google Scholar 

  21. Weström L. Affect of acute pelvic inflammatory disease on fertility. Am J Obstet Gynecol 1975;121:707–713.

    PubMed  Google Scholar 

  22. Weström L. Introductory address: Treatment of pelvic inflammatory disease in view of etiology and risk factors. Sex Trans Dis 1984;11:437–440.

    Article  Google Scholar 

  23. Katz B, Danos C, Quinn T, et al. Efficiency and cost-effectiveness of field follow-up for patients with Chlamydia trachomatis infection in a sexually transmitted disease clinic. Sex Trans Dis 1988;15:11–16.

    Article  CAS  Google Scholar 

  24. Centers for Disease Control. Pelvic inflammatory disease: Guidelines for prevention and management. MMWR 1991;40(No. RR-5):1–25.

    Google Scholar 

Download references

Authors
  1. Nancy S. Padian
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Eugene Washington
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Reproductive Infectious Diseases and Immunology, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Magee-Women’s Hospital, Pittsburgh, PA, 15213-3180, USA

    Daniel V. Landers M.D. (Associate Professor and Director) (Associate Professor and Director)

  2. Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Magee-Women’s Hospital, Pittsburgh, PA, 15213-3180, USA

    Richard L. Sweet M.D. (Professor and Chairman) (Professor and Chairman)

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer Science+Business Media New York

About this chapter

Cite this chapter

Padian, N.S., Washington, A.E. (1997). Risk Factors for Pelvic Inflammatory Disease and Associated Sequelae. In: Landers, D.V., Sweet, R.L. (eds) Pelvic Inflammatory Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-0671-2_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-0671-2_2

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-6863-5

  • Online ISBN: 978-1-4612-0671-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation